Structure Therapeutics (GPCR) Times Interest Earned (2022 - 2026)
Structure Therapeutics' (GPCR) quarterly Times Interest Earned came in at -$111.72 in Q1 2026, down 19.04% year-on-year from -$138.0 in Q1 2025, and down 472.58% quarter-over-quarter from $29.99 in Q4 2025.
Structure Therapeutics (GPCR) Times Interest Earned (2022 - 2026) Analysis & Trends
Structure Therapeutics' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$111.72 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 19.04% year-over-year to -$111.72 in Q1 2026; TTM through Mar 2026 was -$80.63, a 33.74% increase from a year earlier, with the FY2025 full-year figure at -$0.7, up 70.04% from the prior year.
- Times Interest Earned eased to -$111.72 in Q1 2026 per GPCR's latest filing, from $29.99 in the prior quarter.
- Across five years, Times Interest Earned topped out at $29.99 in Q4 2025 and bottomed at -$139.6 in Q2 2022.
- The 5-year median for Times Interest Earned is -$55.3 (2025), against an average of -$56.63.
- Biggest YoY gain for Times Interest Earned was 125.49% in 2025; the steepest drop was 32020.63% in 2025.
- Year by year, Times Interest Earned stood at -$129.56 in 2022, then surged by 40.19% to -$77.48 in 2023, then plunged by 51.84% to -$117.65 in 2024, then surged by 125.49% to $29.99 in 2025, then sank by 472.58% to -$111.72 in 2026.
- Per Business Quant, the three latest GPCR Times Interest Earned figures stand at -$111.72 (Q1 2026), $29.99 (Q4 2025), and -$9.31 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Structure Therapeutics | 11.04 Bn | 11.04 Bn | - | -111.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -111.72 |
| Dec 31, 2025 | 29.99 |
| Sep 30, 2025 | -9.31 |
| Jun 30, 2025 | -55.30 |
| Mar 31, 2025 | -93.85 |
| Dec 31, 2024 | -117.65 |
| Sep 30, 2024 | -0.43 |
| Jun 30, 2024 | -0.37 |
| Mar 31, 2024 | -0.29 |
| Dec 31, 2023 | -77.49 |
| Sep 30, 2023 | -0.16 |
| Jun 30, 2023 | -0.20 |
| Mar 31, 2023 | -0.34 |
| Dec 31, 2022 | -129.56 |
| Sep 30, 2022 | -126.93 |
| Jun 30, 2022 | -139.60 |
| Mar 31, 2022 | -129.52 |